4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001140361-18-026543
10% owner bought 69,444 shares at $18.00 ($1,249,992)
- 10% owner acquired 830,999 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Cormorant Asset Management, LP · 10% owner
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-05-29 | Conversion : show line 1 in the form | +830,999 | 830,999 | I | ||
| 2018-05-29 | Purchase : show line 2 in the form | +69,444 | $18.00 | $1,249,992 | 900,443 | I |
| Open-market purchases · 69,444 sh · avg $18.00 · $1,249,992 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-05-29 | Conversion : show line 3 in the form Series C Preferred Shares | −830,999 | 0 | D |
Loading xslF345X03/doc1.xml…